Keywords: pfizer, net, income, soars, first, quarter, boosted
Pfizer net income soars 45% for the first quarter, boosted by alliance
Article | 18 April 2000
Pfizer has announced first-quarter 2000 revenues of $4.31 billion, anincrease of 10% over the like, year-earlier period, while net income rose 45% to $1.18 billion ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
